相关实验视频

Updated: Jul 28, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

作为选择性RIPK1抑制剂的新型循环马洛纳米德衍生物的设计,合成和生物评估

József Levente Petró1, Gyula Bényei1, Péter Bana1

  • 1Chemical Works of Gedeon Richter Plc, 30-32 Gyömrői Street, Budapest H-1103, Hungary.

Bioorganic & medicinal chemistry letters
|February 5, 2024
PubMed
概括

研究人员开发了新的马洛纳米德抑制剂,向受体相互作用的氨酸/氨酸蛋白激酶1 (RIPK1),这是炎症和细胞死亡的关键因素. 最有前途的化合物在97个激酶中表现出高选择性.

关键词:
抑制剂的抑制剂马洛诺胺胺是什么意思尸体灭 (Necroptosis) 是一种死亡的过程.在RIPK1中使用.选择性的选择性综合合成 综合合成

更多相关视频

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

11.9K
Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays11:17

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays

Published on: June 13, 2019

7.3K

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...